Clinical proof demand outrages UK supplement makers; CRO goes CDISC;
> U.K. supplement makers and health food manufacturers are angry that regulators are beginning to demand clinical data that supports label claims. Blog | Video
> CRO Max Neeman International now offers CDISC services and modified solutions, including ongoing and legacy clinical data conversion, implementation of CDISC standards and CDISC compliance checks. Release
> Mobile drug reference tool maker Epocrates has named Jake Winebaum, an Internet incubator co-founder, to its board. Release
> Bay Clinic in Hawaii will receive $805,000 in stimulus funding over two years to support information technology improvements including hardware, a data center and enhancements to electronic practice management. Article
> The Patient Recruitment Organization has elected Robert Loll as vice chairman. Release
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities

SHARE
WITH: